Last reviewed · How we verify

NCT06741631

MyPEEPS LITE Trial

Recruiting now NA Last updated 27 February 2026
What this trial tests

NA trial testing MyPEEPS Mobile in HIV/AIDS in 3,200 participants. Currently enrolling.

Timeline
10 January 2025
Primary endpoint
1 December 2027
1 December 2028

Quick facts

Lead sponsorColumbia University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment3,200
Start date10 January 2025
Primary completion1 December 2027
Estimated completion1 December 2028
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Columbia University

Who can join

Adults 16 to 29, male only, with HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MyPEEPS Mobile

Trials testing the same drug.

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

Other Columbia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06741631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing